CL Tian is the CEO and Co-Founder of Phiex Technologies, an award-winning, self-sterilizing platform for making life-saving medical devices. Medtech leaders bring terminal sterilization in-house without capital equipment by using Phiex materials to replace EtO, gamma, and E-beam. Phiex was voted by industry the Global Champion of Medtech Innovator 2022, #1 out of 1,000+ companies Seed to Series C, and has been featured in Medical Design & Outsourcing, MD+DI, MassDevice, DeviceTalks, and Medtech Strategist.
CL previously founded a firm specialized in business development for novel technologies and services in industries such as healthcare, SaaS, and B2B services. She served as a Mastermind at Babson College’s WIN Lab, a premier accelerator for women-led companies, and President of ACE NextGen Boston, the Asian Chamber of Commerce. CL graduated magna cum laude from Wellesley College and speaks Mandarin, Japanese, and Korean.
